Fulgent Genetics (FLGT) Market Capitalization (2016 - 2026)

Fulgent Genetics has disclosed Market Capitalization across 11 years of filings, most recently posting $564.6 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 7.21% year-over-year to $564.6 million; the TTM figure through Jun 2026 stood at $564.6 million (down 7.21% YoY), while the FY2025 annual figure was $816.5 million, up 43.34% from the prior year.
• Market Capitalization came in at $564.6 million for Q2 2026 at Fulgent Genetics, up from $458.7 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.9 billion in Q1 2022 to a low of $458.7 million in Q1 2026.
• Average Market Capitalization over 5 years is $854.7 million, with a median of $750.2 million recorded in 2023.
• Year-over-year, Market Capitalization slumped 71.1% in 2022 and soared 43.34% in 2025.
• Over 5 years, Market Capitalization stood at $876.7 million in 2022, then slipped by 2.21% to $857.3 million in 2023, then slumped by 33.55% to $569.6 million in 2024, then soared by 43.34% to $816.5 million in 2025, then slumped by 30.85% to $564.6 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $564.6 million in Q2 2026, $458.7 million in Q1 2026, and $816.5 million in Q4 2025.